Paracetamol Accord (Paracetamol)

Paracetamol works by inhibiting central cyclooxygenase enzymes, mainly COX‑2, which lowers prostaglandin production in the brain and spinal cord. This action reduces the perception of pain and resets the hypothalamic temperature set‑point, resulting in analgesic and antipyretic effects.

The specific dose of Paracetamol Accord is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and renal or hepatic function. Healthcare professionals follow local guidelines and product labeling to set the appropriate infusion rate and total amount.

Safety data for intravenous paracetamol in pregnancy and lactation are limited, and the product’s pregnancy category is listed as unknown. Clinicians should weigh potential benefits against risks and consider alternative therapies when treating pregnant or nursing individuals.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Paracetamol Accord offers rapid onset via the intravenous route, which can be advantageous over oral formulations when immediate effect is needed or oral intake is not possible. Compared with NSAIDs, it lacks significant anti‑inflammatory activity but also carries a lower risk of gastrointestinal irritation and platelet inhibition.

Paracetamol Accord should be stored at ambient temperature, protected from light and moisture, and kept in its original packaging until use. The solution must be inspected for particulate matter or discoloration before administration and should be used within the period indicated on the label after reconstitution.

Paracetamol Accord is administered intravenously by slow infusion, typically through a peripheral or central venous line. The infusion rate and total dose are set by the prescribing clinician, and the solution should be administered using aseptic technique to avoid contamination.

Serious risks include anaphylactic reactions, severe hypotension, hepatic dysfunction, Stevens‑Johnson syndrome, blood dyscrasias, and acute renal failure. Prompt recognition of these events and immediate medical intervention are essential to mitigate harm.

Paracetamol Accord should be avoided in patients with known hypersensitivity to paracetamol or any excipients in the formulation, in those with severe hepatic impairment, and in individuals who have experienced severe adverse reactions to paracetamol administered intravenously.